IndraLab

Statements

Hydroxychloroquine inhibits bZiPro construct NS2B-NS3 protease. 1 / 1

| 1

eidos

"Hydroxychloroquine [ Figure 3 ( 26 ) ] , a drug already approved and used in pregnancy , can inhibit the bZiPro construct of NS2B-NS3 protease activity with an inhibition constant ( Ki ) of 92.34 + / - 11.91 muM ( Table 3 ; Kumar et al ., 2018 ) ."

31866959

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Hydroxychloroquine inhibits bZiPro construct NS2B-NS3 protease. 1 / 1

INDRA sources:

Databases

Reading